skip to Main Content

Benchmark Survey Results

Summary

A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.

Panelists

Moderator
Matt Brow , President

Matt Brow is president of Avalere Health and leads all the firm’s operations, practices, and functions.

Back To Top